Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.

MLA

Dueckelmann, A. M., et al. “Correction to: The Use of PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) in Gynecological Oncology: A Statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.” Archives of Gynecology and Obstetrics, vol. 297, no. 4, Apr. 2018, p. 847. EBSCOhost, https://doi.org/10.1007/s00404-018-4715-7.

APA

Dueckelmann, A. M., Fink, D., Harter, P., Heinzelmann, V., Marth, C., Mueller, M., Reinthaller, A., Tamussino, K., Wimberger, P., & Sehouli, J. (2018). Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland. Archives of Gynecology and Obstetrics, 297(4), 847. https://doi.org/10.1007/s00404-018-4715-7

Chicago

Dueckelmann, A M, D Fink, P Harter, V Heinzelmann, C Marth, M Mueller, A Reinthaller, K Tamussino, P Wimberger, and J Sehouli. 2018. “Correction to: The Use of PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) in Gynecological Oncology: A Statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.” Archives of Gynecology and Obstetrics 297 (4): 847. doi:10.1007/s00404-018-4715-7.